Scholarly Index
Omar Dabbous
Tris Pharma (United States); 8,260 total citations; 220 total publications; best world rank #398
Tris Pharma (United States)
8,260Total citations
220Total publications
37H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Neurogenetic and Muscular Disorders Research | Lifetime | 892 | US 339 | 93.39 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 991 | US 266 | 86.62 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 420 | US 113 | 87.85 |
| Pharmaceutical Economics and Policy | 2021-2025 | 500 | US 169 | 80.63 |
| Congenital Anomalies and Fetal Surgery | 2021-2025 | 741 | US 142 | 70.93 |
| Biomedical Ethics and Regulation | 2021-2025 | 398 | US 168 | 72.39 |